ICON Central Laboratories Expands its European Facility to Meet Growing Demand
14 Dezembro 2009 - 8:12AM
Business Wire
ICON plc, (NASDAQ:ICLR), a global provider of outsourced
development services to the pharmaceutical, biotechnology and
medical device industries, today announced that it has expanded its
European Central Laboratory, located in South County Business Park,
Dublin. The newly-designed 41,000 sq ft (3,800m²) facility, which
is three times the size of the previous laboratory, provides
centralised testing and site support services to clinical
investigators in over 70 countries throughout Europe, Middle East
and Africa.
The new laboratory incorporates enhanced automation which will
enable reductions in turn-around time for sample testing and
reporting, and has quadrupled the laboratory’s sample management
and storage capacity. In addition, the larger facility has enabled
the introduction of new platforms to enhance ICON’s test menu in
specialised areas including microbiology, molecular diagnostics,
flow cytometry, endocrinology and RIA. New dedicated laboratories
have also been created to accommodate more specialised testing
services in the areas of anatomic pathology, molecular diagnostics
and multiplex assays, which will be operational in early 2010.
“Efficient sample management and reporting, and providing an
extensive test menu are key fundamentals of any laboratory,”
commented Peter Gray, CEO at ICON plc. “The extra capacity in our
Dublin laboratory enables ICON to extend our capabilities to
support clients’ demands for more sophisticated testing. ICON
Central Laboratories Dublin will continue to act as an important
central hub for global trials and we look forward to delivering
effective laboratory services to an even greater number of sponsors
and investigators around the world.”
About ICON plc
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The Company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. ICON currently
has around 7,000 employees, operating from 68 locations in 38
countries.
Further information is available at www.iconplc.com
ICON/ICLR-G
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024